Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Ethicon Proceed Lawsuit Claims Multi-Layered Hernia Mesh Design Defective April 22, 2019 Irvin Jackson Add Your Comments The multi-layered design of the Ethicon Proceed hernia patch is defective and unreasonably dangerous, according to allegations raised in a recently filed lawsuit, indicating that users face an increased risk of hernia mesh complications. Robert Esbrandt filed the complaint (PDF) this month in New Jersey Superior Court against Johnson & Johnson, and it’s Ethicon subsidiary, indicating that he suffered damages and permanent injuries due to the defective nature of the Ethicon Proceed mesh. According to the lawsuit, Esbrandt underwent a hernia repair surgery in December 2011, during which an Ethicon Proceed was implanted into his body. However, in February 2013 and again in April 2014, he required revision surgery to have the patch removed, and he had to undergo a third revision surgery in January. Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Esbrandt alleges that the multi-layered hernia mesh design was defective, resulting in the need for the patch to be removed from his body. “Defendants knew that the oxidized regenerated cellulose layer of the Ethicon Multi-Layered Hernia Mesh was ineffective at preventing adhesion formation to the underlying polypropylene of the Proceed before Defendants set out to design the Proceed Ventral Patch in 2006, and even before Defendants set out to design the Proceed Surgical Mesh predicate device in 2003,” the lawsuit states. “Defendants designed, manufactured, and marketed the Ethicon Multi-Layered Hernia Mesh, despite long-standing knowledge that the materials utilized in the Proceed would cause dense adhesions, chronic pain, mesh shrinkage, bowel obstructions, and early hernia recurrence.” The lawsuit indicates that the manufacturers failed to warn Esbrandt and his doctors about the true risks of Ethicon Proceed hernia mesh complications, failed to perform any clinical trials or studies to properly evaluate the safety and effectiveness of the product, and continues to market the hernia mesh without warning of the potential health risks. The case joins a growing number of similar Ethicon hernia mesh lawsuits pending in courts nationwide, most of which involve problems with the previously recalled Physiomesh product, which is another multi-layer polypropylene hernia patch that was removed from the market after it was linked to reports of problems. Esbrant presents claims of defective design, failure to warn, manufacturing defect, negligence and breach of warranty. He seeks both compensatory and punitive damages. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Ethicon, Ethicon Proceed Mesh, Hernia, Hernia Mesh, Johnson & Johnson Image Credit: |test caption More Hernia Mesh Lawsuit Stories Covidien ProGrip Hernia Mesh Lawsuit Joins Over 2,200 Similar Claims in MDL January 9, 2026 Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 November 24, 2025 Feb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge November 5, 2025 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: today) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITLink Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)Ozempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025) Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (Posted: yesterday) A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITLawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (12/30/2025)Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025) Covidien ProGrip Hernia Mesh Lawsuit Joins Over 2,200 Similar Claims in MDL (Posted: 4 days ago) A New York man has filed a Covidien ProGrip hernia mesh lawsuit after requiring corrective surgery due to complications allegedly caused by the implant. MORE ABOUT: HERNIA MESH LAWSUITCovidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (11/24/2025)Feb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: today) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITLink Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)Ozempic, Mounjaro Side Effects May Increase Risk of Cough: Study (12/03/2025)
Lawsuit Claims Dupixent Side Effects Led to CTCL Cancer Diagnosis (Posted: yesterday) A Dupixent lawsuit claims that side effects of the eczema drug led to the development of a rare form of T-cell lymphoma. MORE ABOUT: DUPIXENT LAWSUITLawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (12/30/2025)Dupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)
Covidien ProGrip Hernia Mesh Lawsuit Joins Over 2,200 Similar Claims in MDL (Posted: 4 days ago) A New York man has filed a Covidien ProGrip hernia mesh lawsuit after requiring corrective surgery due to complications allegedly caused by the implant. MORE ABOUT: HERNIA MESH LAWSUITCovidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (11/24/2025)Feb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)